New Study on Tamoxifen Benefit
August 15, 2011
The benefits of taking the breast cancer drug Tamoxifen for five years appear to lower the risk for the disease for an additional ten years.
Topics:
Health Medical Pharma, Social Issues, AstraZeneca, Selective estrogen receptor modulators, Medicine, Tamoxifen, Study of Tamoxifen and Raloxifene, Risk factors of breast cancer, Breast cancer, treatment of bipolar disorder, Cancer, disease
